Chester County News and Community Website
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) announced that its management team will host a live fireside chat on Tuesday, April 22, 2025, at 10:00 a.m. EDT to discuss …
Century Therapeutics Hosts Live Fireside Chat on Groundbreaking Cell Therapy Advances Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) outlined a strategic pipeline re-prioritization and shared its financial results for the year 2024. This move aims to focus on potentially groundbreaking programs …
Century Therapeutics Announces Strategic Pipeline Shift and 2024 Financial Results Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has cemented a collaboration with renowned cell therapy leaders Professors Georg Schett and Andreas Mackensen to initiate a Phase 1/2 trial exploring its …
Century Therapeutics Partners with Experts for New Trial on Autoimmune Diseases Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced its financial results and business updates for the third quarter of 2024, highlighting significant progress in its clinical trials and …
Century Therapeutics Expands Clinical Focus and Reports Steady Financials for Q3 2024 Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced key leadership changes with the appointments of Morgan Conn, Ph.D., as Chief Financial Officer and Chad Cowan, Ph.D., as Chief …
Century Therapeutics Announces Strategic Leadership Appointments Read More